(Q37812319)

23 August 2017

Role of glial cells in neurotoxin-induced animal models of Parkinson's disease (English)

1 reference

23 August 2017

1 reference

Hironori Yokoyama

1

1 reference

23 August 2017

Hiroto Uchida

2

1 reference

23 August 2017

Hayato Kuroiwa

3

1 reference

23 August 2017

Jiro Kasahara

4

1 reference

23 August 2017

Tsutomu Araki

5

1 reference

23 August 2017

24 November 2010

1 reference

23 August 2017

Neurological Sciences

1 reference

23 August 2017

32

1 reference

23 August 2017

1

1 reference

23 August 2017

1-7

1 reference

https://scigraph.springernature.com/pub.10.1007/s10072-010-0424-0

23 August 2017

0 references

cites work

Neuroprotection for Parkinson's disease: prospects and promises

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Molecular pathophysiology of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Glial reactions in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Microglial physiology: unique stimuli, specialized responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Parametric mapping of [18F]FPCIT binding in early stage Parkinson's disease: a PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Within and between sample comparisons of Gompertz parameters for Salmonella enteritidis and aerobic plate counts in chicken stored in air and modified atmosphere.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Parkinson's disease: mechanisms and models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Toxin-induced models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Evidence for generation of oxidative stress in brain by MPTP: in vitro and in vivo studies in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Biochemical, behavioral and immunohistochemical alterations in MPTP-treated mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Glutathione peroxidase, glial cells and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Molecular profile of reactive astrocytes--implications for their role in neurologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Microglia: Intrinsic immuneffector cell of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Cytotoxicity of microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Neurotrophic factors: from molecule to man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Apoptosis in Parkinson's disease: signals for neuronal degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Selective injury to dopaminergic neurons up-regulates GDNF in substantia nigra postnatal cell cultures: role of neuron-glia crosstalk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

MANF: a new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Astrocytes protect neurons from nitric oxide toxicity by a glutathione-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Microglia in cell culture and in transplantation therapy for central nervous system disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Microglial activation and dopamine terminal loss in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Free radicals in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Oxidative stress in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Dopamine but not 3,4-dihydroxy phenylacetic acid (DOPAC) inhibits brain respiratory chain activity by autoxidation and mitochondria catalyzed oxidation to quinone products: implications in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Presence of reactive microglia in monkey substantia nigra years after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Up-regulation of inducible nitric oxide synthase in the substantia nigra by lipopolysaccharide causes microglial activation and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Trisialoganglioside GT1b induces in vivo degeneration of nigral dopaminergic neurons: role of microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Role of Fcgamma receptors in nigral cell injury induced by Parkinson disease immunoglobulin injection into mouse substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Mitochondrial dysfunction in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Functional recovery in parkinsonian monkeys treated with GDNF

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Glutathione, oxidative stress and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Primate models of movement disorders of basal ganglia origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Some Immunohistochemical Features of Argyrophilic Grain Dementia With Normal Cortical Choline Acetyltransferase Levels but Extensive Subcortical Pathology and Markedly Reduced Dopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Caspase-mediated oligodendrocyte cell death in the pathogenesis of autoimmune demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Effects of steroid hormones on gene expression of glial markers in the central and peripheral nervous system: variations induced by aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Rapid alteration of tau in oligodendrocytes after focal ischemic injury in the rat: involvement of free radicals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Grey matter and white matter ischemic damage is reduced by the competitive AMPA receptor antagonist, SPD 502.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Injury to axons and oligodendrocytes following endothelin-1-induced middle cerebral artery occlusion in conscious rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Ebselen protects both gray and white matter in a rodent model of focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

Decreased brain levels of 2',3'-cyclic nucleotide-3'-phosphodiesterase in Down syndrome and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-010-0424-0

The parkinsonian toxin MPTP: action and mechanism.

21 January 2018

1 reference

12 December 2020

The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease

1 reference

12 December 2020

Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons

1 reference

12 December 2020

Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia

1 reference

12 December 2020

Animal models of parkinsonism using selective neurotoxins: clinical and basic implications.

1 reference

12 December 2020

Role of cytokines in inflammatory process in Parkinson's disease.

1 reference

12 December 2020

Glia: a curtain raiser

1 reference

12 December 2020

Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

1 reference

12 December 2020

Description of Parkinson's disease as a clinical syndrome.

1 reference

12 December 2020

Glial cell participation in the degeneration of dopaminergic neurons in Parkinson's disease

1 reference

12 December 2020

Glial cell line-derived neurotrophic growth factor inhibits apoptotic death of postnatal substantia nigra dopamine neurons in primary culture

1 reference

12 December 2020

Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization

1 reference

12 December 2020

Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease.

1 reference

12 December 2020

Studies on the characterization of the inhibitory mechanism of 4'-alkylated 1-methyl-4-phenylpyridinium and phenylpyridine analogues in mitochondria and electron transport particles

1 reference

12 December 2020

Implication of the subthalamic nucleus in the pathophysiology and pathogenesis of Parkinson's disease.

1 reference

12 December 2020

Tau protein is altered by focal cerebral ischaemia in the rat: an immunohistochemical and immunoblotting study

1 reference

12 December 2020

Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization

1 reference

12 December 2020

Lewy bodies in Parkinson's disease are recognized by antibodies to complement proteins

1 reference

12 December 2020

Damage to oligodendrocytes in the striatum after MPTP neurotoxicity in mice

1 reference

12 December 2020

Apoptosis in neurodegenerative disorders

1 reference

12 December 2020

Astrocytes and Parkinson's disease

1 reference

12 December 2020

10.1007/S10072-010-0424-0

Identifiers

DOI

1 reference

23 August 2017

1 reference